Up to this day, the SARS-CoV-2 virus is posing a global threat. The world has experienced the virus’ potential for adaption and mutation, and several variants of concern have emerged since the beginning of the pandemic, leading to many serious COVID-19 outbreaks worldwide.
Since the clinical symptoms of a COVID-19 infection are not clear and can be confused with other common respiratory diseases, the precise and reliable detection of a COVID-19 infection is essential for the efficient containment of this highly contagious disease.
Convergent Technologies offers different COVID-19 Detection Kit configurations to meet your individual requirements.
The genus Mycobacterium contains several pathogenic species that can cause serious diseases in humans. The most prominent disease is tuberculosis (TB), a chronic infectious disease which mostly affects the lungs (pulmonary TB), but can also affect other parts of the body, including the abdomen and the nervous system (extrapulmonary TB).
Tuberculosis is still a major health problem worldwide, especially due to the continuous spread of multidrug-resistant tuberculosis. According to WHO, an estimate of 10 million people worldwide fell ill with Tuberculosis in 2020, of which 1.5 million people died, making it the second leading cause of death from an infectious disease after COVID-19.
Prevention of TB involves screening those at high risk, early detection and treatment of cases.
Convergent Technologies offers different Mycobacteria Detection Kit configurations to meet your individual requirements.
Vector transmitted infections are caused by pathogens, which rely on third party host organisms (vector) for propagation. One of the most prevalent pathogenic vectors are mosquitos, which are known to transmit numerous infectious diseases. While this used to concern primarily tropical regions, the ongoing climate change is increasing the regions which are affected by mosquito transmitted infections.